Assessment of the lipid lowering effect of rosuvastatin compared to atorvastatin in subjects with coronary heart disease

Study identifier:D3560L00039

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

A Multicentre Study Comparing the Efficacy of Rosuvastatin with Atorvastatin When Given for a Period of 16 Wks to Subjects with Coronary Heart Disease & a Previously Performed Percutaneous Coronary Intervention

Medical condition

Coronary heart disease

Phase

Phase 4

Healthy volunteers

No

Study drug

-

Sex

All

Actual enrollment

255

Study type

Interventional

Age

18 Years +

Date

Study Start Date: 01 Jan 2004
Primary Completion Date: 01 Mar 2006
Study Completion Date: 01 Mar 2006

Study design

Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Double Blind
Primary Purpose: None

Verification:

Verified 01 Nov 2013 by AstraZeneca Pharmaceuticals

Sponsors

AstraZeneca Pharmaceuticals

Collaborators

-

Inclusion and exclusion criteria